Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU684
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,683
Award facts
- Contract value 100% obligated
- $12,682.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens valued at $12,682.70. This non-set-aside, competitively awarded contract is structured as a delivery order under a firm fixed-price arrangement, with performance to be completed by December 15, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the company's ongoing capability to fulfill federal medical supply requirements for both routine and specialty medications as part of DLA's pharmaceutical support operations.
Quick answers
Who was awarded contract SPE2DR26FU684?
SPE2DR26FU684 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FU684 worth?
The government has obligated $12,683 on SPE2DR26FU684.
Is contract SPE2DR26FU684 an order under another contract?
Yes. SPE2DR26FU684 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU684 competed?
The extent of competition for SPE2DR26FU684 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award